Search results

Page results

• Research at UCLH to tackle RSV infections in infants

  UCLH will play a vital role in a new respiratory virus study.

• London hospitals partner up to run event for children and young people with sickle cell disorder at the Tottenham Hotspur Stadium

  North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.

• Patient-initiated follow-up (PIFU) for women with endometrial cancer

  This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.

• Managing diabetes at Christmas - 2020

  Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.

• 1,000 RSV vaccines administered at UCLH

  UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.

• Bolstering world-class research in Women’s Health at UCLH

  UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.

• Meet the maternity teams

  While you're pregnant you will have a nominated professional lead which will be a midwife or an obstetrician.

• Charity at UCLH

  Information about our UCLH Charity, charity funds and associated charities.

• Managing High Glucose Levels and Ketones with insulin pumps (that are not Hybrid Closed Loop Systems)

  This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using an insulin pump.

• Clinical Research Facility at UCLH awarded £10 million

  The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.